Logo image
Phase-contrast magnetic resonance imaging for analyzing hemodynamic parameters and wall shear stress of pulmonary arteries in patients with pulmonary arterial hypertension
期刊文章   同儕審查

Phase-contrast magnetic resonance imaging for analyzing hemodynamic parameters and wall shear stress of pulmonary arteries in patients with pulmonary arterial hypertension

Hung-Hsuan Wang, Wen-Yih Isaac Tseng, Hsi-Yu Yu, Meng-Chu ChangHsu-Hsia Peng
Magnetic Resonance Materials in Physics, Biology and Medicine
2019

摘要

Flow velocity Magnetic resonance imaging Pulmonary arterial hypertension Wall shear stress Biophysics Radiological and Ultrasound Technology Radiology Nuclear Medicine and Imaging
Objective: To investigate flow-related parameters in pulmonary arteries of patients with pulmonary arterial hypertension (PAH). Materials and methods: Eleven PAH patients and twelve control participants were recruited. PAH and controls had similar age and gender distribution. 2D phase-contrast MRI (PC-MRI) was performed in the main, right, and left pulmonary artery (MPA, RPA, and LPA). The flow velocity, wall shear stress (WSS), and oscillatory shear index (OSI) were measured. Results: PAH patients displayed prolonged acceleration time (T ) and increased ratio of flow change to acceleration volume in pulmonary arteries (both P < 0.001). The temporally averaged WSS values of MPA, RPA, and LPA in PAH patients were significantly lower than those of control participants (P < 0.001). The OSI in the pulmonary arteries was higher in PAH patients than control participants (P < 0.05). The ROC analysis indicated the ratio of maximum flow change to acceleration volume, WSS, and T exhibited sufficient sensitivity and specificity to detect patients with PAH. The WSS demonstrated strong correlations with T and the ratio value in the two groups (R = 0.78–0.96). Conclusions: We used a clinically feasible 2D PC-MRI sequence with a reasonable scanning time to compute aforementioned indices. The quantitative parameters provided sufficient information to differentiate PAH patients from control participants.

相關連結

指標

1 檢視次數

詳細資料

Logo image